Publications by authors named "M Hamzink"

Claim this Profile
T
The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against .
Robert M F van der Put, Carolien Smitsman, Alex de Haan, Martin Hamzink, Hans Timmermans

ACS Cent Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay.
Thomas J M Michiels, Wichard Tilstra, Martin R J Hamzink, Justin W de Ridder, Maarten Danial

Vaccines (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Formaldehyde-Induced Modifications of Lysine Residue Pairs in Peptides and Proteins: Identification and Relevance to Vaccine Development.
Thomas J M Michiels, Christian Schöneich, Martin R J Hamzink, Hugo D Meiring, Gideon F A Kersten

Mol Pharm· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stabilised aluminium phosphate nanoparticles used as vaccine adjuvant.
Hilde Vrieling, Margarita Espitia Ballestas, Martin Hamzink, Geert-Jan Willems, Peter Soema

Colloids Surf B Biointerfaces· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trypsin diminishes the rat potency of polio serotype 3.
R ten Have, J Westdijk, L M A R Levels, P Koedam, A de Haan, M R J Hamzink

Biologicals· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis